Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Cash Flow-to-Debt Ratio
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Cash Flow-to-Debt Ratio of -0.02x as of June 2023, meaning its operating cash flow of €-64.53 Million could theoretically repay 0% of its total liabilities (€3.97 Billion) in one year. Explore 2TZ long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited across 13 annual periods. Also explore how large is Tianjin Zhong Xin Pharmaceutical Group C's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2025)
Year-by-year debt coverage analysis for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited. For market capitalisation and broader financial context, see 2TZ company net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | €461.07 Million | €4.59 Billion | ▼ -68.3% |
| 2024 | 0.32x | €924.67 Million | €2.92 Billion | ▲ +65.0% |
| 2023 | 0.19x | €688.49 Million | €3.58 Billion | ▲ +2.2% |
| 2022 | 0.19x | €677.25 Million | €3.61 Billion | ▼ -43.7% |
| 2021 | 0.33x | €852.40 Million | €2.55 Billion | ▲ +16.0% |
| 2020 | 0.29x | €671.42 Million | €2.33 Billion | ▲ +34.7% |
| 2019 | 0.21x | €495.49 Million | €2.32 Billion | ▲ +25.1% |
| 2018 | 0.17x | €350.14 Million | €2.05 Billion | ▲ +8679.3% |
| 2017 | 0.00x | €-3.97 Million | €2.00 Billion | ▼ -101.0% |
| 2016 | 0.20x | €417.77 Million | €2.06 Billion | ▲ +10.5% |
| 2015 | 0.18x | €360.58 Million | €1.96 Billion | ▲ +59.4% |
| 2014 | 0.12x | €286.85 Million | €2.49 Billion | ▲ +45.0% |
| 2013 | 0.08x | €213.44 Million | €2.69 Billion | — |